Stay updated on Immunotherapy for Bladder Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.

Latest updates to the Immunotherapy for Bladder Cancer Patients Clinical Trial page
- Check6 days agoChange DetectedAdded a dedicated Locations section with New Jersey and New York, replacing the previous separate location entries. Updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure footer link.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not all be about the study. The revision label is updated to v3.3.2, replacing v3.2.0.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding lapse notice regarding site operations has been removed from the page.SummaryDifference0.3%

- Check63 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03520491; the content remains focused on trial objectives, design, eligibility criteria, and locations.SummaryDifference0.3%

- Check85 days agoChange DetectedUpdated page now includes a government funding status notice and a new version v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check92 days agoChange DetectedUpdated page revision to v3.1.0 and added two new contact numbers; removed the older revision v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy for Bladder Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.